Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinxue Liao

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
JCI Insight|March 20, 2025
A cardiac fibroblast-enriched micropeptide regulates inflammation in ischemia/reperfusion injuryYouchen Yan, Tingting Zhang, Xin He, et al.
BMJ Open|July 11, 2023
Alirocumab effect on preventing periprocedural ischaemic events in coronary heart disease patients undergoing coronary stenting (APPEASE trial): study protocol of a multicentre, open-label, randomised controlled trialZhuoshan Huang, Xiaodong Zhuang, Shaozhao Zhang, et al.
Cardiovascular Research|March 21, 2023
The translational landscape of human vascular smooth muscle cells identifies novel short open reading frame-encoded peptide regulators for phenotype alterationKang Li, Bin Li, Dihua Zhang, et al.
ESC Heart Failure|April 10, 2025
Dapagliflozin effect on functional mitral regurgitation and myocardial remodelling: The DEFORM trialZhuoshan Huang, Rui Fan, Shaozhao Zhang, et al.
Frontiers in Cardiovascular Medicine|March 17, 2022
Loss of m<sup>6</sup>A Methyltransferase METTL5 Promotes Cardiac Hypertrophy Through Epitranscriptomic Control of SUZ12 ExpressionYanchuang Han, Tailai Du, Siyao Guo, et al.
International Journal of Medical Sciences|November 28, 2022
Identification of Novel Phenotypes Correlated with CKD: A Phenotype-Wide Association StudyYifen Lin, Jianqiu Kong, Ting Tian, et al.
Cardiovascular Research|July 8, 2026
Long noncoding RNA CARDINAL cis-activates MYOCD expression by recruiting histone reader ZZZ3 in vascular smooth muscle cell phenotype alterationHuimin Zhou, Shaozhao Zhang, Xingfeng Xu, et al.
JACC. Advances|February 3, 2025
Equations for Predicting the 10-Year Risk of Atherosclerotic Cardiovascular Disease in Population With ObesityYi Zhou, Menghui Liu, Zhuohui Chen, et al.
Frontiers in Cardiovascular Medicine|April 4, 2022
Cardiac ISL1-Interacting Protein, a Cardioprotective Factor, Inhibits the Transition From Cardiac Hypertrophy to Heart FailureYouchen Yan, Tianxin Long, Qiao Su, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 17, 2021
Cardiac CIP protein regulates dystrophic cardiomyopathyXin He, Jianming Liu, Fei Gu, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
JCI Insight|March 20, 2025
A cardiac fibroblast-enriched micropeptide regulates inflammation in ischemia/reperfusion injuryYouchen Yan, Tingting Zhang, Xin He, et al.
BMJ Open|July 11, 2023
Alirocumab effect on preventing periprocedural ischaemic events in coronary heart disease patients undergoing coronary stenting (APPEASE trial): study protocol of a multicentre, open-label, randomised controlled trialZhuoshan Huang, Xiaodong Zhuang, Shaozhao Zhang, et al.
Cardiovascular Research|March 21, 2023
The translational landscape of human vascular smooth muscle cells identifies novel short open reading frame-encoded peptide regulators for phenotype alterationKang Li, Bin Li, Dihua Zhang, et al.
ESC Heart Failure|April 10, 2025
Dapagliflozin effect on functional mitral regurgitation and myocardial remodelling: The DEFORM trialZhuoshan Huang, Rui Fan, Shaozhao Zhang, et al.
Frontiers in Cardiovascular Medicine|March 17, 2022
Loss of m<sup>6</sup>A Methyltransferase METTL5 Promotes Cardiac Hypertrophy Through Epitranscriptomic Control of SUZ12 ExpressionYanchuang Han, Tailai Du, Siyao Guo, et al.
International Journal of Medical Sciences|November 28, 2022
Identification of Novel Phenotypes Correlated with CKD: A Phenotype-Wide Association StudyYifen Lin, Jianqiu Kong, Ting Tian, et al.
Cardiovascular Research|July 8, 2026
Long noncoding RNA CARDINAL cis-activates MYOCD expression by recruiting histone reader ZZZ3 in vascular smooth muscle cell phenotype alterationHuimin Zhou, Shaozhao Zhang, Xingfeng Xu, et al.
JACC. Advances|February 3, 2025
Equations for Predicting the 10-Year Risk of Atherosclerotic Cardiovascular Disease in Population With ObesityYi Zhou, Menghui Liu, Zhuohui Chen, et al.
Frontiers in Cardiovascular Medicine|April 4, 2022
Cardiac ISL1-Interacting Protein, a Cardioprotective Factor, Inhibits the Transition From Cardiac Hypertrophy to Heart FailureYouchen Yan, Tianxin Long, Qiao Su, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 17, 2021
Cardiac CIP protein regulates dystrophic cardiomyopathyXin He, Jianming Liu, Fei Gu, et al.
Pageof 14